NCT04772261View on ClinicalTrials.gov

GEBT Lot-to-Lot and Biological Variability

NACompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions

Gastroparesis

Interventions

DIAGNOSTIC_TEST

13C-Spirulina GEBT

Various lots of 13C-Spirulina GEBT test meals

Trial Locations (1)

37027

Cairn Diagnostics, Brentwood

Sponsors

Lead Sponsor

Cairn Diagnostics

All Listed Sponsors

lead

Cairn Diagnostics

INDUSTRY

NCT04772261 - GEBT Lot-to-Lot and Biological Variability | Biotech Hunter | Biotech Hunter